Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
23.59
-0.12 (-0.51%)
At close: Dec 5, 2025, 4:00 PM EST
23.40
-0.19 (-0.81%)
After-hours: Dec 5, 2025, 5:20 PM EST
Edgewise Therapeutics Market Cap
Edgewise Therapeutics has a market cap or net worth of $2.50 billion as of December 5, 2025. Its market cap has decreased by -16.30% in one year.
Market Cap
2.50B
Enterprise Value
1.94B
1-Year Change
-16.30%
Ranking
Category
Stock Price
$23.59
Market Cap Chart
Since the IPO on March 26, 2021, Edgewise Therapeutics's market cap has increased from $761.07M to $2.50B, an increase of 228.15%. That is a compound annual growth rate of 28.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 2.50B | -1.22% |
| Dec 31, 2024 | 2.53B | 264.15% |
| Dec 29, 2023 | 694.27M | 22.85% |
| Dec 30, 2022 | 565.13M | -24.97% |
| Dec 31, 2021 | 753.24M | -1.03% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |